Font Size:
a
A
A
Keyword [neoadjuvant-immunotherapy]
Result: 1 - 19 | Page: 1 of 1
1.
Curative Effect Of Neoadjuvant Chemo-immunotherapy In Locally Advanced Lung Squamous Cell Carcinoma
2.
CXCL5 Predict The Efficacy Of Neoadjuvant Immunotherapy For Esophageal Cancer And Its Correlation With Tumor Microenvironment
3.
1.Prognostic Value Of TIGIT/CD47 Expression In Lung Squamous Cell Carcinoma 2.Efficacy Of Anti-PD-1/PD-L1 Neoadjuvant Immunotherapy And Surgery In Lung Squamous Cell Carcinoma
4.
Efficacy And Safety Of Neoadjuvant Immunotherapy Plus Chemotherapy In Subjects With Resectable Esophageal Squamous Cell Carcinoma
5.
Research On Predictive Markers For The Efficacy Of Neoadjuvant Immunotherapy In Non-small Cell Lung Cancer Based On Multi-omics Technology
6.
Efficiency Prediction And Prognostic Evaluation Of Neoadjuvant Chemoimmunotherapy For Potentially Resectable Non-small Cell Lung Cancer
7.
Study On The Effect Of PD-1 Immune Checkpoint Inhibitor Combine With Chemotherapy Neoadjuvant Treatment Of Stage ⅢA/ⅢB Lung Squamous Cell Carcinoma
8.
Analysis Of Clinical Factors Influencing MPR Of Neoadjuvant Immunotherapy For Potential Resectable Non-small Cell Lung Cancer
9.
A Retrospective Examination Of The Effectiveness And Security Of Robot-less Invasive Surgery In Comparison To Traditional Thoracoscopic Surgery In The Treatment Of Lung Cancer After Neoadjuvant Immunotherapy Combined With Chemotherapy Was Conducted
10.
Neoadjuvant Therapy With Immune Checkpoint Inhibitors Can Reduce The Risk Of Postoperative Recurrence Of Resectable NSCLC
11.
Clinical Outcomes Of Neoadjuvant Immunotherapy Combined With Chemotherapy In The Treatment Of Locally Advanced Resectable Squamous Oesophageal Cancer
12.
Clinical Study Of Neoadjuvant Chemo-immunotherapy In Locally Advanced Esophageal Squamous Cell Carcinoma
13.
Analysis Of The Characteristics And Predictive Factors Of Adverse Reactions And Complications During The Perioperative Period Of Neoadjuvant Immunotherapy Combined With Chemotherapy In NSCLC
14.
Efficacy And Feasibility Of Neoadjuvant Immunotherapy Combined With Chemotherapy For Resectable Non-Small Cell Lung Cancer:A Meta-Analysis
15.
Application Of PET-CT Radiomics In The Treatment Of Pathological Complete Response By Neoadjuvant Immunotherapy Combined With Chemotherapy In Patients With Esophageal Squamous Cell Carcinoma
16.
Meta-analysis Of Efficacy And Safety Of Neoadjuvant Immunotherapy And Neoadjuvant Chemotherapy In The Treatment Of Non-small Cell
17.
Meta Analysis Of The Efficacy And Safety Of Neoadjuvant Immunotherapy Combined With Chemotherapy For Stage Ⅲ Non Small Cell Lung Cancer
18.
An Observational Study On The Clinical Effects Of Neoadjuvant Immunotherapy Combined With Chemotherapy For Locally Advanced Esophageal Cancer
19.
CT-based Radiomics Predicting The Good Pathological Response For Neoadjuvant Immunotherapy In Non-small Cell Lung Cancer
<<First
<Prev Next>
Last>>
Jump to